BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/22/2021 10:39:22 AM | Browse: 630 | Download: 1890
 |
Received |
|
2021-02-02 02:57 |
|
Peer-Review Started |
|
2021-02-02 03:02 |
|
First Decision by Editorial Office Director |
|
2021-03-08 06:37 |
|
Return for Revision |
|
2021-03-08 06:37 |
|
Revised |
|
2021-03-19 17:43 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2021-04-25 12:41 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2021-04-25 13:20 |
|
Articles in Press |
|
2021-04-25 13:20 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-05-14 02:20 |
|
Publish the Manuscript Online |
|
2021-05-22 10:39 |
| ISSN |
2218-4333 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Pathology |
| Manuscript Type |
Minireviews |
| Article Title |
Hepatic Langerhans cell histiocytosis: A review
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Zhiyan Fu, Hua Li, Mustafa Erdem Arslan, Peter F Ells and Hwajeong Lee |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Hwajeong Lee, MD, Associate Professor, Department of Pathology and Laboratory Medicine, Albany Medical Center, 47 New Scotland Ave., MC81, Albany, NY 12208, United States. leeh5@amc.edu |
| Key Words |
Langerhans cell; Liver; Cholangitis; CD1a |
| Core Tip |
Hepatic Langerhans cell histiocytosis (LCH) is characterized by proliferation and accumulation of Langerhans cells in the liver, causing liver dysfunction or forming a mass lesion. There are diverse injury patterns on liver biopsy, including lobular Langerhans cell infiltrate with mixed inflammatory background, primary biliary cholangitis-like pattern, sclerosing cholangitis-like pattern, and even cirrhosis at later stage. The overall prognosis of hepatic LCH is poor. New molecular markers involved in pathogenesis of LCH are being explored with a potential for targeted therapy. |
| Publish Date |
2021-05-22 10:39 |
| Citation |
Fu Z, Li H, Arslan ME, Ells PF, Lee H. Hepatic Langerhans cell histiocytosis: A review. World J Clin Oncol 2021; 12(5): 335-341 |
| URL |
https://www.wjgnet.com/2218-4333/full/v12/i5/335.htm |
| DOI |
https://dx.doi.org/10.5306/wjco.v12.i5.335 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
